Literature DB >> 11359872

Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.

H Jurevics1, J Hostettler, E D Muse, D W Sammond, G K Matsushima, A D Toews, P Morell.   

Abstract

We studied markers of myelin content and of the rate of myelination in brains of mice between 8 and 20 weeks of age. During the 12-week time-course, control animals showed slight increases in the content of oligodendroglial-specific cerebroside, as well as cholesterol (enriched in, but not specific to, myelin). In contrast, synthesis of these lipids, as assayed by in vivo incorporation of (3)H(2)O, was substantial, indicating turnover of 0.4% and 0.7% of total brain cerebroside and cholesterol, respectively, each day. We also studied mice exposed to a diet containing 0.2% of the copper chelator, cuprizone. After 6 weeks 20%, and by 12 weeks, over 30% of brain cerebroside was gone. Demyelination was accompanied by down-regulation of mRNA expression for enzymes controlling myelin lipid synthesis (ceramide galactosyl transferase for cerebroside; hydroxymethylglutaryl-CoA reductase for cholesterol), and for myelin basic protein. Synthesis of myelin lipids was also greatly depressed. The 20% cerebroside deficit consequent to 6 weeks of cuprizone exposure was restored 6 weeks after return to a control diet. During remyelination, expression of myelin-related mRNA species, as well as cerebroside and cholesterol synthesis were restored to normal. However, in contrast to the steady state metabolic turnover in the control situation, all the cerebroside and cholesterol made were accumulated. To the extent that accumulating cerebroside is targeted for eventual inclusion in myelin (discussed) the rate of its synthesis is proportional to remyelination. With our assay, in vivo rates of cerebroside synthesis can be determined for a time window of the order of hours. This offers greater temporal resolution and accuracy relative to classical methods assaying accumulation of myelin components at time intervals of several days. We propose this experimental design, and the reproducible cuprizone model, as appropriate for studies of how to promote remyelination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359872     DOI: 10.1046/j.1471-4159.2001.00310.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

Review 2.  Dietary Polar Lipids and Cognitive Development: A Narrative Review.

Authors:  Lu Zheng; Mathilde Fleith; Francesca Giuffrida; Barry V O'Neill; Nora Schneider
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

3.  Turnover of myelin lipids in aging brain.

Authors:  Susumu Ando; Yasukazu Tanaka; Yuriko Toyoda; Kazuo Kon
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

4.  An Altered Sphingolipid Profile as a Risk Factor for Progressive Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD).

Authors:  Sara Tucci
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

5.  Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides.

Authors:  Natalia A Crivello; Sherley L Casseus; James W Peterson; Donald E Smith; Sarah L Booth
Journal:  J Nutr Biochem       Date:  2010-01-25       Impact factor: 6.048

Review 6.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

7.  Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice.

Authors:  Kirk Pak; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

8.  Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation.

Authors:  Nicholas J Kuypers; Andrew N Bankston; Russell M Howard; Jason E Beare; Scott R Whittemore
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

9.  Links between copper and cholesterol in Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Sharon La Fontaine
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

Review 10.  Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.

Authors:  C Sevin; P Aubourg; N Cartier
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.